Wednesday, November 18, 2026 MAURITIUS Edition Independent Journalism
Breaking
HIV/AIDS colloquium in Mauritius turns focus to governance
Oceania

HIV/AIDS colloquium in Mauritius turns focus to governance

Regional health officials confront funding shortfalls and legal barriers to care

The 22nd edition of the Colloque Océan Indien on HIV/AIDS, held in Mauritius from 18 to 20 November, brought together the actors of the regional response at a moment when the governance of the epidemic itself has become the central question. Organized under the banner “Océan Indien : Combler l’écart” and documented by Sidaction, whose account of the gathering is available at https://www.sidaction.org/transversal/ocean-indien-combler-lecart-retours-sur-la-22eme-edition-du-colloque-ocean-indien-vih-sida-a-maurice/, the colloquium framed its debates around four priorities: the evolution of the epidemic, access to care, prevention innovations and regional cooperation.

The institutional picture opened with an address by Dr Jude Padayachy, Secretary of State for Health of the Seychelles, who assessed the international and regional situation against the targets set by UNAIDS for 2030. On the agency’s own figures, those targets remain out of reach. Nearly 41 million people were living with HIV worldwide in 2025. New infections have fallen over the past fifteen years, to 1.2 million cases in 2025, yet 570,000 people still died of AIDS-related illnesses that year.

The cascade of care indicators shows where policy is working and where mandates are unmet. UNAIDS estimates that 88 percent of people living with HIV know their status, 89 percent of those diagnosed are on antiretroviral treatment, and 95 percent of those treated have a suppressed viral load. These are real gains toward the 95-95-95 objectives, but children are being left behind by current systems: only 65 percent know their status and 84 percent have access to treatment. Dr Padayachy placed particular weight on a structural fragility, the decline in international funding. With roughly 9 million people still without access to antiretroviral treatment and nearly half of children living with HIV deprived of care, shrinking donor contributions now threaten the progress of recent decades.

Within the region, the data presented exposed starkly divergent trajectories, and with them divergent tests of state capacity. Madagascar is the principal source of concern. Since 2010 the country has recorded a 288 percent rise in new infections and a 130 percent increase in AIDS-related deaths, running counter to trends across most of southern Africa. In the Comoros, the picture is more stable: seropositivity discoveries have remained broadly steady from 2010 to 2024, AIDS-related mortality has fallen by nearly half, prevalence among those aged 15 to 49 stays below 0.1 percent according to UNAIDS, and fewer than 500 people live with HIV. Even so, 2025 data show a rise in new infections, a signal of continuing active transmission that public authorities cannot ignore.

Mauritius, host of the colloquium, counts between 10,000 and 12,000 people living with HIV and records around 630 new infections a year, with an upward trend among those aged 15 to 44. Prevalence is concentrated in key populations, a pattern that places specific demands on policy: transgender people, people who inject drugs, sex workers and detained people show prevalence rates of 28.4 percent, 21.2 percent, 18.2 percent and 17.3 percent respectively.

Beyond national statistics, the strongest governance argument of the colloquium came on its first day, from Dr Joy Backory, former UNAIDS country director in Burkina Faso and director of Nexus Impact, a consultancy specializing in health public policy. In an intervention titled “Quand la politique, le droit et la société soignent le VIH et les addictions,” he argued that the medical toolkit already exists and that the international targets for reducing new infections by 2030 could be met without a vaccine or any further major therapeutic innovation. The obstacle, he said, is no longer scientific but institutional and legal: stigma, discrimination, the criminalization of certain behaviors and a lack of trust in institutions keep people away from testing, prevention and care services. “Les droits humains sont un déterminant de la santé,” he reminded the audience. His comparison with the West African Ebola epidemic made the point in institutional terms: there, public health measures collided with funerary practices and lost much of their effect, and HIV follows the same logic when purely medical responses ignore social realities.

Dr Backory’s case studies were, at bottom, arguments about how states exercise their responsibilities. He cited the “Buladi” campaign in the Indian state of West Bengal, designed by the agency Ogilvy & Mather Kolkata around a rag puppet playing an approachable elder sister, which helped authorities break taboos and create the conditions for using testing and treatment services that generic antiretrovirals alone could not reach. The Thai example was the most striking. After the heavily repressive “war on drugs” launched by Prime Minister Thaksin Shinawatra in the early 2000s, the Thai Drug Users Network sustained harm reduction activities, information sharing, access to injection and prevention materials, and peer support, for nearly twenty years. In 2021 the government reformed its drug legislation, wrote harm reduction into law, and progressively integrated community-run services into the national health system to secure their future. In Senegal, the consortium ENDA Santé worked in close coordination with the Conseil national de lutte contre le sida and the Ministry of Health to develop services for the most exposed populations, each party holding a clearly defined role, although repression and violence targeting LGBTQ+ people have intensified since the beginning of 2026.

The colloquium closed, in Dr Backory’s formulation, on three levers that condition the effectiveness of public health responses: a favorable legal framework, genuine trust in and involvement of communities to improve access to care, and political will capable of removing obstacles to prevention, testing and treatment. For the region’s governments and agencies, the measure of accountability is now whether those levers are pulled before the funding decline turns warning signals into reversals.

Q&A

Who opened the institutional proceedings at the colloquium and what did he assess?

Dr Jude Padayachy, Secretary of State for Health of the Seychelles, who assessed the regional and international situation against UNAIDS targets for 2030.

What did Dr Joy Backory identify as the main obstacle to meeting the 2030 targets?

Dr Joy Backory, former UNAIDS country director in Burkina Faso and director of Nexus Impact, argued the obstacle is institutional and legal: stigma, discrimination, criminalization and lack of trust in institutions keep people away from services.

Which country in the region is the principal source of concern and why?

Madagascar, with a 288 percent rise in new infections and a 130 percent increase in AIDS-related deaths since 2010, running counter to trends across most of southern Africa.

What three levers did Dr Backory say condition the effectiveness of public health responses?

A favorable legal framework, genuine trust in and involvement of communities to improve access to care, and political will capable of removing obstacles to prevention, testing and treatment.